KEGG   DRUG: Cizutamig
Entry
D13214                      Drug                                   
Name
Cizutamig (USAN/INN)
Sequence
(A chain)
DIQMTQSPSS LSASVGDRVT ITCGASENIY GALNWYQQKP GKAPKLLIYG ATNLATGIPS
RFSGSGSGRD FTLTISSLQP EDFATYYCQS VLTTPWTFGQ GTKLEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGECEVQLVQ SGAEVKKPGA SVKVSCKASG
FSFTNYYVHW MRQAPGQGLE WIGWISPGSD NTKYNEKFKG RVTLTADTSI STAYMELSRL
RSDDTAVYYC ARDDYGNYYF DYWGQGTTVT VSSASTKGPS VFPLAPSSKS TSGGTAALGC
LVKDYFPEPV TVSWNSGALT SGVHTFPAVL QSSGLYSLSS VVTVPSSSLG TQTYICNVNH
KPSNTKVDKK VEPKSCDKTH TCPPCPAPEA AGGPSVFLFP PKPKDTLMIS RTPEVTCVVV
DVSHEDPEVK FNWYVDGVEV HNAKTKPREE QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS
NKALPAPIEK TISKAKGQPR EPQVYTLPPS REEMTKNQVS LTCLVKGFYP SDIAVEWESN
GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS CSVMHEALHN HYTQKSLSLS
PGK
(B chain)
EVQLVQSGAE VKKPGASVKV SCKASGYTFT NFWMHWVRQA PGQRLEWMGA FYPGNDDTYY
NQKFKGRVTI TADTSASTAY MELSSLRSED MAVYYCARSG YYGSSDAMDY WGQGTTVTVS
SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKVE PKSC
(C chain)
DIVMTQSPDS LAVSLGERAT INCKSSQSLL NARTRKNYLA WYQQKPGQPP KLLIYWASTR
ESGVPDRFSG SGSGTDFTLT ISSLQAEDVA VYYCKQSYIL RTFGGGTKVE IKRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: A23-A88, A134-A194, A214-B224, A236-A310, A360-A416, A436-C219, A442-A'442, A445-A'445, A477-A537, A583-A641, A'23-A'88, A'134-A'194, A'214-B'224, A'236-A'310, A'360-A'416, A'436-C'219, A'477-A'537, A'583-A'641, B22-B96, B148-B204, B'22-B'96, B'148-B'204, C23-C94, C139-C199, C'23-C'94, C'139-C'199)
  Type
Peptide
Efficacy
Antineoplastic, Immunostimulant
  Type
Bispecific antibody
Comment
Treatment of multiple myeloma
Target
TNFRSF17 (BCMA, CD269) [HSA:608] [KO:K05153]
CD3E [HSA:916] [KO:K06451]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04640  Hematopoietic cell lineage
hsa04672  Intestinal immune network for IgA production
Brite
Target-based classification of drugs [BR:br08310]
 Signaling molecules and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF17 (BCMA, CD269)
     D13214  Cizutamig (USAN/INN)
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD3E
     D13214  Cizutamig (USAN/INN)
Other DBs
CAS: 2919209-65-5
PubChem: 522705664
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system